Stocks in News, Q4 RESULTS IN BRIEF: JBCHEM, EMCUREPHARMA, ZYDUSLIFE, DIVISLAB, YESBANK, INDIGO, TCS, ICICIBANK, HDFCLIFE
AHMEDABAD, 21 APRIL: Emcure Pharma: Company announced the receipt of the Establishment Inspection Report (EIR) from the USFDA for its API manufacturing facility in Kurkumbh. (Positive) JB Chemicals: Company has received US FDA approval for its ANDA for Bisoprolol Tablets USP, 5 mg and 10 mg. (Positive) Dynamatic Technologies: CompanyContinue Reading







